Latest Protein Sciences Stories

2010-11-03 08:00:00

MERIDEN, Conn., Nov. 3, 2010./PRNewswire/ -- Protein Sciences Corporation (PSC) announced today that the Company and its management have reached an agreement with Emergent BioSolutions, Inc (Emergent) resolving all remaining issues from the failed attempt by Emergent to purchase PSC's assets in June 2008. As a result, all litigation will be dismissed with prejudice and all other entanglements between the two companies will be ended. Daniel Adams, Executive Chairman, said, "With this deal...

2010-02-18 13:01:00

MERIDEN, Conn., Feb. 18 /PRNewswire/ -- Protein Sciences Corporation (PSC) announced today that its Board of Directors adopted a succession plan under which Dr. Manon Cox, MBA, currently the Company's Chief Operating Officer, has been elected President and Chief Executive Officer effective March 1, 2010. Daniel Adams, currently Chairman, President and CEO will then assume the role of Executive Chairman. PSC also announced that 2009 was a solidly profitable and cash flow positive year...

2009-09-14 15:51:00

MERIDEN, Conn., Sept. 14 /PRNewswire/ -- Protein Sciences Corporation (PSC) announced today that the United States Bankruptcy Court in Delaware granted PSC's motion to dismiss the involuntary bankruptcy case filed against it by Emergent BioSolutions, Inc. The Court found the involuntary bankruptcy was not in the best interests of PSC and its creditors. About PSC PSC is a privately held biopharmaceutical company based in Meriden, Connecticut, whose mission it is to save lives and improve...

2009-06-24 06:10:00

On Tuesday, the Department of Health and Human Services announced that a U.S. company was awarded a $35 million contract to develop a flu vaccine using insect cell technology. "The technology has advanced in recent years to a point that we believe it could help meet a surge in demand for US-based vaccine for seasonal and pandemic flu," said U.S. Health Secretary Kathleen Sebelius. The A(H1N1) virus, commonly referred to as swine flu, emerged in Mexico in April and has killed 231 people...

2009-06-15 08:00:00

Approximately 100,000 doses can be manufactured per week MERIDEN, Conn., June 15 /PRNewswire/ -- Protein Sciences Corporation (PSC) announced that today it commenced manufacturing of a vaccine to protect humans against the H1N1 "swine flu" virus. The Company estimates that it can produce 100,000 doses this week and at least 100,000 doses per week thereafter. The vaccine, called PanBlok(R), is made using PSC's proprietary baculovirus and insect cell manufacturing technology. PSC believes...

Word of the Day
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.